Physician profile
Abdo Kabarriti
NPI 1306138136
$9,010.56
in general payments reported to CMS, 2019-2025
7 companies · $6,644 in 2025
The $6,644 reported for 2025 was more than what 92% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.23 · 2020: $121 · 2021: $31.72 · 2022: $85.21 · 2023: $2,022 · 2024: $58.52 · 2025: $6,644.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,300 · Travel and Lodging: $1,769 · Food and Beverage: $655.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,300.00 |
| Travel and Lodging | $1,769.12 |
| Food and Beverage | $655.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $6,920.18 | 2020-2025 | Ams 800 Artificial Urinary Sphincter, General - Erectile Dysfunction, Ams 700 |
| Procept Biorobotics Corporation | $1,923.41 | 2023 | Aquabeam Robotic System |
| Verity Pharmaceuticals INC. | $83.37 | 2022-2025 | Tlando |
| Intuitive Surgical, INC. | $35.37 | 2023 | Da Vinci Surgical System |
| Ethicon US, LLC | $18.88 | 2019 | |
| Astellas Pharma US INC | $14.81 | 2019 | |
| Pfizer INC. | $14.54 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Abdo Kabarriti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.